Cleveland Clinic study identified genetic anomaly associated with poor response to common asthma treatment
On Jan. 13, 2020, a new Cleveland Clinic study uncovered a genetic anomaly associated with poor response to…
Genentech drug Xolair (omalizumab) was approved
On Jun. 20, 2003, Genentech drug Xolair (omalizumab) was approved by the U. S. Food and Drug Administration…
Stanford researchers identified a novel gene family involved in asthma
On Nov. 19, 2001, researchers at Lucile Packard Children’s Hospital at Stanford announced they had identified a novel…
Biotechnology | Disease | Energy | Environmental | EPA | Life Science News | Neurology
The Environmental Protection Agency took final step in phaseout of leaded gasoline
On Jan. 29, 1996, Environmental Protection Agency (EPA) Administrator Carol M. Browner took the last steps concluding a…
Biology | Disease | Environmental | EPA | Life Science News | Neurology
The EPA sets new limits on lead in gasoline
On Mar. 4, 1985, the Environmental Protection Agency (EPA) Administrator Lee M. Thomas announced final standards to cut…
CDC | Disease | Energy | Environmental | EPA | Life Science History | Neurology
The CDC revealed blood lead levels related to gasoline exposure, leading to fuel changes by the EPA
In 1976, the U.S. Centers for Disease Control and Prevention’s (CDC) Environmental Services Division revealed blood lead levels…
Disease | Energy | Environmental | EPA | FDA | Life Science History | Neurology | U.S. Congress
The Environmental Protection Agency required the phase-out of lead in gasoline
On Nov. 28, 1973, the Environmental Protection Agency (EPA) Administrator Russell E. Train announced the final regulations to…
Biology | Disease | Environmental | EPA | FDA | Life Science History | Neurology | U.S. Congress
William Mansfield Clark alerted the public to the dangers of tetraethyl lead in gasoline
In 1923, William Mansfield Clark from the U.S. Department of Agriculture alerted the public to the dangers of…